AP Trademark

Trademark Overview

On Friday, February 18, 2005, a trademark application was filed for AP with the United States Patent and Trademark Office. The USPTO has given the AP trademark a serial number of 78570329. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 10, 2020. This trademark is owned by Actimis Pharmaceuticals, Inc.. The AP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders
ap

General Information

Serial Number78570329
Word MarkAP
Filing DateFriday, February 18, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 10, 2020
Registration Number3636768
Registration DateTuesday, June 9, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 25, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders
Pseudo MarkACTIMIS PHARMACEUTICALS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 10, 2020
Primary Code042
First Use Anywhere DateFriday, December 31, 2004
First Use In Commerce DateFriday, December 31, 2004

Trademark Owner History

Party NameActimis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, January 10, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 9, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 26, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 26, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 26, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 18, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2010REVIEW OF CORRESPONDENCE COMPLETE
Monday, January 11, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 21, 2009PAPER RECEIVED
Tuesday, June 9, 2009REGISTERED-PRINCIPAL REGISTER
Wednesday, May 6, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, May 6, 2009ASSIGNED TO LIE
Wednesday, May 6, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 20, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 16, 2009USE AMENDMENT FILED
Monday, April 20, 2009EXTENSION 5 GRANTED
Thursday, April 16, 2009EXTENSION 5 FILED
Thursday, April 16, 2009TEAS EXTENSION RECEIVED
Thursday, April 16, 2009TEAS STATEMENT OF USE RECEIVED
Friday, October 17, 2008EXTENSION 4 GRANTED
Tuesday, October 14, 2008EXTENSION 4 FILED
Wednesday, October 15, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 14, 2008TEAS EXTENSION RECEIVED
Monday, April 21, 2008EXTENSION 3 GRANTED
Friday, April 11, 2008EXTENSION 3 FILED
Friday, April 11, 2008TEAS EXTENSION RECEIVED
Tuesday, October 23, 2007EXTENSION 2 GRANTED
Sunday, October 14, 2007EXTENSION 2 FILED
Sunday, October 14, 2007TEAS EXTENSION RECEIVED
Thursday, July 19, 2007EXTENSION 1 GRANTED
Monday, April 9, 2007EXTENSION 1 FILED
Thursday, May 31, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 31, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 9, 2007TEAS EXTENSION RECEIVED
Tuesday, October 17, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2006NOTICE OF PUBLICATION
Wednesday, June 7, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 31, 2006ASSIGNED TO LIE
Thursday, May 18, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 20, 2006AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 5, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2006PAPER RECEIVED
Monday, October 3, 2005NON-FINAL ACTION E-MAILED
Monday, October 3, 2005NON-FINAL ACTION WRITTEN
Thursday, September 15, 2005ASSIGNED TO EXAMINER
Tuesday, July 5, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 2, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

drug research pharmaceutical inflammatory field candidates auto anti respiratory immunity